Keyword: Aragon Pharmaceuticals


Roche to Buy US Biotech Firm Seragon for up to $1.7 Billion

03.07.2014 - Swiss-based Roche Holding AG plans to pay up to $1.73 billion to buy Seragon Pharmaceuticals, a privately-held US biotech company that researches breast cancer treatments. Roche...


J&J in $1 Billion Deal to Bolster Prostate-Cancer Focus

18.06.2013 - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired...